ScholarLens Back to search
2006•Zhonghua xingwei yixue yu naokexue zazhiRequires access

A control study on the curative effect and reliability of reboxetine with fluoxetine for treatment of depression

Jindong Chen

Open publisher page 1 citations

Abstract

Objective To evaluate efficacy and safety of reboxetine in treating depression.Methods In this randomized,double-blind,double-mimicry,fluoxetine parallel controlled,the study group was treated with reboxetine capsule and the control group with fluocetine.Hamilton Rating Scale for Depression was taken to evalu- ate efficacy score while.Results At the end of six weekend,compared with the total scores of HAMD before and after treatment,rebocetine(16.8±5.8)and fluoxctine(16.0±6.3)group both showed the significant differ- enee,while the difference compared between two groups,the efficacy(78.6% and 64.3%)for depression and side effects were no significance.Conclusion Reboxetine is a efficient and safety antidepressant.

About this research paper

What this paper is about

Objective To evaluate efficacy and safety of reboxetine in treating depression.Methods In this randomized,double-blind,double-mimicry,fluoxetine parallel controlled,the study group was treated with reboxetine capsule and the control group with fluocetine.Hamilton Rating Scale for Depression was taken to evalu- ate efficacy score while.Results At the end of six weekend,compared with the total scores of HAMD before and after treatment,rebocetine(16.8±5.8)and fluoxctine(16.0±6.3)group both showed the significant differ- enee,while the difference compared between two groups,the efficacy(78.6% and 64.3%)for depression and side effects were no significance.Conclusion Reboxetine is a efficient and safety antidepressant.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate efficacy and safety of reboxetine in treating depression.Methods In this randomized,double-blind,double-mimicry,fluoxetine parallel controlled,the study group was treated with reboxetine capsule and the control group with fluocetine.Hamilton Rating Scale for Depression was taken to evalu- ate efficacy score while.Results At the end of six weekend,compared with the total scores of HAMD before and after treatment,rebocetine(16.8±5.8)and fluoxctine(16.0±6.3)group both showed the significant differ- enee,while the difference compared between two groups,the efficacy(78.6% and 64.3%)for depression and side effects were no significance.Conclusion Reboxetine is a efficient and safety antidepressant.

Key concepts: Reboxetine, Hamd, Fluoxetine, Antidepressant, Depression (economics), Psychology, Significant difference, Rating scale

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A control study on the curative effect and reliability of reboxetine with fluoxetine for treatment of depression — Research Paper | ScholarLens